[Page Banner Image]

The following is a review of diagnostic product developments worldwide

The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.

The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.

[HRule Image]

Product developments in December 2006

Biomoda, Inc. signed an agreement to exclusively license cancer detection technology from Los Alamos National Laboratory. Biomoda's cancer detection technology is based on a patented porphyrin application that preferentially binds to cancerous or aberrant cells, which are non-invasively collected from lung sputum samples. The porphyrin then glows red under fluorescent light, easily identifying cancerous cells. This simple optical reading of a molecular cancer test is easily automated, permitting rapid, accurate, and inexpensive cancer screening of large populations.

Diagnostic Hybrids and Immunicon Corporation signed a definitive license, development, supply and distribution agreement to develop and commercialize products for virus detection. The first product is a panel of multiplex respiratory virus and sexually transmitted infection assays. Instruments and kits developed under the agreement will be sold exclusively by DHI. The clinical virology product portfolio will be developed for Immunicon's EasyCount System.

Ortho-Clinical Diagnostics received FDA clearance to market its Ortho T. cruzi Elisa Test System, a test to screen blood donors for T. cruzi, a blood-borne parasite that causes Chagas disease. In addition to screening donated whole blood, the test can screen plasma and serum samples from organ, cell and tissue donors. The test is not currently approved to diagnose the disease, the FDA said.

Procter & Gamble Co. invested $325 million in a joint venture with Inverness Medical Innovations. The OTC medical devices will be made by Inverness and marketed and distributed by Procter & Gamble. The deal, expected to be finalized late in the first quarter of 2007, will not include diagnostics products in cardiology and diabetes.

Response Biomedical Corporation entered into a worldwide, exclusive agreement with the medical division of the 3M Company for the development and commercialization of diagnostic products targeting hospital and community acquired infectious diseases using Response Biomedical's RAMP testing platform. As part of this collaboration, 3M is making an $8 million equity investment in Response Biomedical, representing approximately a 13% ownership position. Response Biomedical will be responsible for development and manufacturing of the RAMP-based products, while 3M will be responsible for clinical and regulatory matters, and all sales, marketing and distribution of the infectious disease tests.

Spectral Diagnostics received FDA clearance to market its rapid test for West Nile Virus. Spectral plans to make the test available in the U.S. in time for the 2007 West Nile Virus season.

Verax Biomedical signed a 10-year agreement with British Biocell International (BBI) to manufacture the Verax Platelet PGD Test. The agreement comes in anticipation of strong worldwide demand for the Platelet PGD Test and follows the recent Verax announcement of an exclusive worldwide distribution agreement with Abbott Diagnostics to market and distribute the test, which is currently being evaluated in clinical trials. The Platelet PGD Test is a rapid, disposable device designed to detect the presence of a broad range of bacterial contaminants in platelets just prior to transfusion.

[HRule Image]

* Product developments - November 2006
* Product developments - October 2006
* Product developments - Summer 2006
* Product developments - May 2006
* Product developments - April 2006
* Product developments - March 2006
* Product developments - February 2006
* Product developments - January 2006
* Product developments - December 2005
* Product developments - October 2005
* Product developments - September 2005
* Product developments - Summer 2005
* Product developments - May 2005
* Product developments - April 2005
* Product developments - March 2005
* Product developments - February 2005
* Product developments - January 2005
* Product developments - December 2004
* Product developments - November 2004
* Product developments - October 2004
* Product developments - September 2004
* Product developments - May 2004
* Product developments - April 2004
* Product developments - March 2004
* Product developments - February 2004
* Product developments - January 2004
* Product developments - December 2003
* Product developments - November 2003
* Product developments - October 2003
* Product developments - September 2003
* Product developments - Summer 2003
* Product developments - May 2003
* Product developments - April 2003
* Product developments - March 2003
* Product developments - April 04003
* Product developments - January 2003
* Product developments - December 2002
* Product developments - November 2002
* Product developments - October 2002
* Product developments - September 2002
* Product developments - Summer 2002
* Product developments - June 2002
* Product developments - May 2002
* Product developments - April 2002
* Product developments - March 2002
* Product developments - April 04002
* Product developments - January 2002
* Product developments - December 2001
* Product developments - November 2001
* Product developments - October 2001
* Product developments - September 2001
* Product developments - Summer 2001
* Product developments - May 2001
* Product developments - April 2001
* Product developments - March 2001
* Product developments - April 04001
* Product developments - January 2001
* Product developments - December 2000
* Product developments - November 2000
* Product developments - October 2000
* Product developments - September 2000
* Product developments - July - August 2000
* Product developments - June 2000
* Product developments - May 2000
* Product developments - April 2000
* Product developments - March 2000
* Product developments - Febuary 2000
* Product developments - January 2000
* Product developments - December 1999
* Product developments - November 1999
* Product developments - October 1999
* Product developments - September 1999
* Product developments - August 1999
* Product developments - July 1999
* Product developments - June 1999
* Product developments - May 1999
* Product developments - April 1999
* Product developments - March 1999
* Product developments - Febuary 1999
* Product developments - January 1999
* Product developments - December 1998
* Product developments - November 1998
* Product developments - October 1998
* Product developments - September 1998
* Product developments - August 1998
* Product developments - July 1998
* Product developments - June 1998
* Product developments - May 1998
* Product developments - Avril 1998
* Product developments - March 1998
* Product developments - February 1998
* Product developments - January 1998
* Product developments - July 1997
* Product developments - June 1997
* Product developments - May 1997
* Product developments - April 1997
* Product developments - March 1997
* Product developments - February 1997
* Product developments - January 1997
* Product developments - December 1996
* Product developments - November 1996
* Product developments - October 1996
* Product developments - September 1996
* Product developments - August 1996
* Product developments - July 1996
* Product developments - June 1996

[HRule Image]

Home | Company Profile | Services | Research Reports Available
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links

[HRule Image]
Send mail to stratcom@total.net with questions or comments about this web site.

Concept and Design Blue Page Productions
Copyright 1996-2007 STRATCOM

Last modified: January 04, 2007